Nkarta to Participate in a September Investor Conference

Rhea-AI Summary

Nkarta (NASDAQ:NKTX), a clinical-stage biopharmaceutical company focused on engineered natural killer (NK) cell therapies, has announced its participation in the H.C. Wainwright 27th Annual Global Investment Conference. The company will engage in a fireside chat on September 9, 2025, at 8:30 a.m. ET.

Investors can access a live webcast of the presentation through Nkarta's website, with a replay available for approximately 90 days following the event.

News Market Reaction – NKTX

-0.94%

-0.94% Session close to close

In the Sep 2 session, NKTX declined 0.94%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation in the following investor conference:

H.C. Wainwright 27^th Annual Global Investment Conference
September 9, 2025
8:30 a.m. ET – fireside chat

A simultaneous webcast of the event will be available on the Investors section of Nkarta’s website, www.nkartatx.com, and a replay will be archived on the website for approximately 90 days.

About Nkarta
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies for autoimmune diseases. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies and CRISPR-based genome engineering capabilities, Nkarta is building a pipeline of future cell therapies engineered for deep therapeutic activity and intended for broad access in the outpatient treatment setting. For more information, please visit the company’s website at www.nkartatx.com.

Nkarta Media/Investor Contact:
Nadir Mahmood
Nkarta, Inc.
nmahmood@nkartatx.com

FAQ

When is Nkarta (NKTX) presenting at the H.C. Wainwright Conference?

Nkarta will present at the H.C. Wainwright Conference on September 9, 2025, at 8:30 a.m. ET in a fireside chat format.

How can investors access Nkarta's (NKTX) H.C. Wainwright Conference presentation?

Investors can access the presentation via a live webcast on Nkarta's website (www.nkartatx.com) in the Investors section. A replay will be available for approximately 90 days.

What is Nkarta's (NKTX) main focus as a company?

Nkarta is a clinical-stage biopharmaceutical company that develops engineered natural killer (NK) cell therapies.

How long will the replay of Nkarta's (NKTX) conference presentation be available?

The replay of the presentation will be archived on Nkarta's website for approximately 90 days.